Navigation Links
Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Date:5/29/2012

AMSTERDAM and IRVINE, Calif., May 29, 2012 /PRNewswire/ -- Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, announced today that it will present nine posters on genomic research studies in breast and colon cancer at the Annual Meeting of the American Society of Clinical Oncology (ASCO). The meeting will be held from June 1-5, 2012, at McCormick Place in Chicago, IL.

Currently on the market in the U.S. and Europe, Agendia's Symphony™ suite of molecular diagnostic breast cancer tests enables physicians to determine whether a given breast cancer patient is likely to benefit from hormonal therapy, chemotherapy and targeted therapies, thereby providing benefits over existing treatment approaches for patients, physicians and payers.

Agendia's lead product, MammaPrint®, is the first and only diagnostic breast cancer recurrence test cleared by the U.S. Food and Drug Administration (FDA). Agendia's product development pipeline includes a further extension of its breast cancer tests as well as similar molecular diagnostic products for colon cancer. 

All of the abstracts listed below can currently be found online at www.ASCO.org.  Presentation details are as follows (all times are in Central Time). 

Friday, June 1, 2012

Colorectal Cancer

1. Poster Presentation & Discussion: Validation of a genomic classifier (ColoPrint) for predicting outcome in the T3-MSS subgroup of stage II colon cancer patients.

  • Lead Author: R. Salazar, J. Tabernero, V. Moreno, U. Nitsche, T. Bachleitner-Hofmann, G. Lanza, L. Stork, P. Roepman, I. Simon, R. Rosenberg
  • Presentation Time: 1:00 PM – 5:00 PM; Location: E450b
  • Discussion Time: 4:30 PM – 5:30
    '/>"/>

SOURCE Agendia
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Agendia Wins 2011 Scrip Award for "Best Partnership Alliance"
2. Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue
3. Agendia Appoints New CEO and Supervisory Board Member
4. Agendia Receives €1.27 Million in Funding from the EUs Seventh Framework Programme
5. Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine
6. Agendia to Provide Testimony at Public Meeting on FDA Oversight of Laboratory-Developed Tests
7. Agendia to Play Pivotal Role in ISPY-2 Trial for Breast Cancer
8. FDA Broadens Clearance for Agendias MammaPrint(R)
9. /C O R R E C T I O N -- Agendia B.V./
10. Agendias Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations
11. Agendias Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... SAN DIEGO , May 17, 2013 /PRNewswire/ ... today that its Fast-Track Advanced Technology Small Business ... National Institute of Allergy and Infectious Diseases (NIAID), ... (NIH), supporting the development of novel human antibody ... S. aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... 2013  Technology advances have had a profound ... a constantly evolving communication environment, companies need to ... with internal executives. It is challenging, however, to ... and tools that are part of today,s communication ... Best Practices, LLC explores the various internal communication ...
(Date:5/17/2013)... May 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... holder and 130um sorting chip.  Sony will also be exhibiting ... new SH800 Cell Sorter, the EC800 flow cytometer, and new ... CYTO 2013, which will be held at the ... Diego, California , from May 20 - 22.  ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Sony Delivers New Technology for Science to CYTO 2013 2
... CITY, Utah, Nov. 4, 2010 NuView Life ... the development of proprietary target specific biomarkers for ... announced today that its applications for the Qualifying ... The grants totaling just over ...
... SALT LAKE CITY, Nov. 4, 2010 ... Mrs. Carla Peacock, from Wylie, Texas. Peacock has eleven years ... Texas, where she audits workers, compensation bills. She was curious ... decided, with the encouragement of her employer, to learn medical ...
Cached Medicine Technology:NuView Life Sciences Awarded Grants Under the Patient Protection and Affordable Care Act of 2010 2AAPC Reaches 100,000 Members 2
(Date:5/19/2013)... Seattle, Wa (PRWEB) May 19, 2013 Agora ... training program that covers guides on how to increase ... an innovative memory training method that helps people re-new their ... fight stress and beat depression caused by a fatigued mind. ... their mind razor sharp for a lifetime. The author claimed ...
(Date:5/19/2013)... 2013 Beginning Wednesday, May 29 and running ... (RRVBC) will feature “Hot Dog Wednesdays" and Ice Cold Slushies ... provide hot dogs and all the fixin's to donors on ... throughout the summer. “Donors are our lifeline. The summer months ... adequate blood supply. This is a small way for ...
(Date:5/19/2013)... Florida (PRWEB) May 19, 2013 ... market access, is pleased to unveil a new and ... environment that provides a powerful array of real-time communication ... in the US and abroad. , HE-Xpo is powered ... offer attendees the look and feel of being at ...
(Date:5/19/2013)... The Da Vinci robot lawyers at Wright ... nation’s first trial involving a Da Vinci surgical robot ... Court, was filed by the widow of a man ... a robot-assisted prostate removal, according to a report from ... lawsuit alleges those complication’s hastened his death. (Estate ...
(Date:5/18/2013)... Daily Gossip issued a press release last week to announce ... Colston, Daily Gossip’s spokesperson, told the press that the magazine ... Fat Loss Plan . , Shaun Hadsall was the ... time when nutritionists and fat loss gurus constantly told people ... diet is based on the Macro-Patterning scheme, according ...
Breaking Medicine News(10 mins):Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4
... SHANGHAI, Sept. 1 /PRNewswire-Asia/ -- Linkwell ... distributor,of healthcare-related disinfectants in China, put forward its worries ... spread of H1N1. , "Antisepsis ... and control,infectious diseases, and it will work best when ...
... , , BARCELONA, Spain, ... in patients treated with LIVALO (pitavastatin), high-density lipoprotein cholesterol ... low-density lipoprotein cholesterol (LDL-C) targets, with results sustained over ... efficacy to atorvastatin and simvastatin, as measured by reduction ...
... last spring , MONDAY, Aug. 31 (HealthDay News) -- As ... campuses, school administrators are beefing up efforts to encourage students ... further. , Signs popping up on campuses across the ... to take the flu seriously, to get seasonal flu shots, ...
... drive within two hours , TUESDAY, Sept. 1 (HealthDay News) ... behind the wheel and drive within two hours of drinking, ... timeline and other new information to what,s known about drinking ... with the alcohol team at the U.S. Centers for Disease ...
... , CHICAGO, Sept. 1 Controlling healthcare costs seems like ... to save our nation billions of dollars. , , ... to Jason Beans, CEO of Chicago-based Rising Medical Solutions , is ... in a different direction. , , "People debate whether ...
... , , , COLUMBUS, ... support for Childhood Cancer Awareness Month by kicking off a new integrated ... Disorders Service of Children,s Healthcare of Atlanta . Childhood cancer is ... age of 15. Through improved research and treatments, childhood cancer survival rates ...
Cached Medicine News:Health News:Which is the Real Terminator of H1N1 Disease, the Antisepsis or the Vaccine? 2Health News:Which is the Real Terminator of H1N1 Disease, the Antisepsis or the Vaccine? 3Health News:LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 2Health News:LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 3Health News:LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 4Health News:LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 5Health News:Swine Flu on Campuses Boosts Call for Vaccinations 2Health News:Driving After Binge Drinking More Common Than Believed 2Health News:Driving After Binge Drinking More Common Than Believed 3Health News:Five Ways to Change America's Healthcare System: 2Health News:Aflac Announces Support for Childhood Cancer Awareness Month 2Health News:Aflac Announces Support for Childhood Cancer Awareness Month 3Health News:Aflac Announces Support for Childhood Cancer Awareness Month 4Health News:Aflac Announces Support for Childhood Cancer Awareness Month 5
... Estrone Enzyme Immunosorbent Assay (EIA) Kit ... of Estrone in serum. The procedure ... immunoassay where there is competition between ... antigen for a fixed number of ...
Helmer's Horizon Series line of refrigerator is designed specifically for the cost conscious buyer. This line offers outstanding performance, quality, and the features you need to ensure the safety o...
... the i.Series refrigerator iB120, ... for the blood bank. ... than ever before, i.Series ... at the forefront of ...
... Designed for the precise requirements of ... Forma Blood Bank Equipment meets American ... National Red Cross (ANRC) and U.S. ... Refrigerators, storage freezers, and platelet incubators ...
Medicine Products: